 A novel folic acid-conjugated TiO 2 -SiO 2 nano-photosensitizer was synthesized for targeted photo-killing of cancer cells  High photodynamic reactivity, improved cell internalization and cellular and blood compatibility were well demonstrated  A strong photo-killing effect on the human nasopharyngeal epidermoid cancer (KB) cells was achieved 3
Introduction
Photodynamic therapy (PDT) has been used for the treatment of various cancers and other diseases [1] . It involves the administration of a photosensitizer (PS), either by systemic or topical application, and subsequent initiation of its exposure to light to produce reactive oxygen species (ROS) that kill the cancer cells via the mechanism of apoptosis or necrosis [2] .
In addition to directly killing tumor cells, ROS also could damage the blood vessels that supply the oxygen and nutrients to the tumor, leading to tumor shrinkage [3] . Compared to conventional cancer therapy, the major advantages of PDT are that the PS is of low toxicity to normal tissue or cells in the dark, and activation by light alone permits minimal damage to these cells [4] . The combined effect of light and PS makes PDT a selective therapy to use against cancerous or diseased tissue. PDT becomes dual-selective when the accumulation of PS is only on cancer cells, which can be achieved through cell-specific targeting [5] .
The commonly used PS drugs are classified as porphyrin-based and nonporphyrin-based.
These PSs often contain large π-conjugation domains and are hydrophobic. Their hydrophobic nature causes aggregation of these relatively large molecules under aqueous physiological conditions, resulting in severely reduced ROS formation that is essential for the PDT effect [6, 7] . The poor selectivity to the targeted tissue due to limited accumulation by classic PS drugs also prevents their clinic applications. Skin hyperphotosensitivity and associated pain are ongoing problems for patients after treatment, due to the limited tumor selectivity and slow body clearance of the currently approved PSs [8, 9] . Despite a large number of studies undertaken over the last decades, the limited selectivity and efficacy are still widely accepted problems for PSs associated with PDT treatments. An ideal PS should have the combined properties of high ROS yield and a great degree of selectivity towards the cancerous cells when used in therapeutic concentration, without damaging the healthy tissue.
Titanium dioxide (TiO 2 ) is a semiconductor-based material, known for its high photosensitivity. It presents a band-gap energy of 3.0 eV. Upon the absorption of a photon with energy that is equal to or higher than this value, TiO 2 can be excited to produce negative electrons in the conduction band, leaving positive holes in the valence band. These charge carriers react with surrounding water or oxygen to yield cytotoxic ROS such as hydroxyl (•OH), hydrogen peroxide (H 2 O 2 ), and superoxide (•O 2 - ). Both the generated holes and ROS are strong oxidizers that can attack cell membranes and other cellular components, leading to apoptosis of cancer cells [10] . TiO 2 nanoparticles also have been proven to be effective in preventing drug efflux caused by multi-drug resistance (MDR), leading to selective accumulation of TiO 2 at the tumor site [11, 12] . They have shown good cytocompatibility in the dark, both in vitro and in vivo [13] . Clinical application of TiO 2 is limited, mostly due to the aggregation of the nanoparticles that leads to a decrease in photocatalytic reactivity [14] , and the lack of specificity to target the cancerous cells. We have demonstrated that encapsulating TiO 2 within a silica shell can improve both the dispersion and cell compatibility of the nanoparticles, whilst maintaining high photodynamic reactivity [10] . The aim of this study is to synthesize folic acid-conjugated (FA-conjugated) TiO 2 , via the functionalized silica shell, and to investigate the cell internalization and cytotoxicity of these nanoparticles, both in the dark and under irradiation, so as to develop a high performance and targeted photosensitizer for cancer treatments that utilize PDT.
FA-conjugated silica-coated TiO 2 (TS-FA) nanoparticles were prepared according to the reaction scheme illustrated in Fig. 1 . First, silica-coated TiO 2 (TS) was synthesized according to our previous work, which was further aminated using (3-aminopropyl)triethoxysilane (APTES) to produce amine-terminated silica-coated TiO 2 (TS-NH 2 ) nanoparticles.
N-Hydroxysuccinimide-ester of folic acid (NHS-FA) then was prepared using the N, 
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Materials
Chemical synthesis
TS-NH 2 nanoparticles were first prepared using the sol-gel method ( temperature for a further 2 h. Following this, the reaction mixture was allowed to cool down to room temperature and centrifuged at 7500 rpm for 10 min. The liquid was discarded and the TS-NH 2 nanoparticles were washed three times with 15 ml of ethanol (3×15 ml), followed by three times with 15 ml of Milli-Q water (3×15 ml) and dried overnight at room temperature under vacuum.
NHS Folate (NHS-FA) was obtained through the DCC coupling reaction (Fig. 1) . In brief, folic acid (5.0 g, 11.3 mmol) and triethylamine (1.8 g, 17.9 mmol) were added to 100 ml of freshly distilled dimethyl sulfoxide (DMSO) at room temperature under constant stirring.
After stirring for 2 h, NHS (2.6 g, 22.6 mmol) and DCC (4.7 g, 22.8 mmol) were added to the mixture. The obtained reaction mixture had a molar ratio of 1.0 folic acid: 1.6 triethylamine:
2.0 NHS: 2.0 DCC. The reaction was allowed to proceed overnight in the dark. Then, the dicyclohexylurea by-product was removed by filtration and the liquid was concentrated in the presence of reduced pressure and heating. The concentrated liquid (1.5 ml) was dispersed in THF (15 ml) with constant shaking to remove the excess amount of DMSO. Then, anhydrous diethyl ether (5 ml) was added into the mixture and the characteristic yellow powder was formed, followed by collection via centrifugation at 7500 rpm for 10 min. The liquid was discarded. After that, the solid was dispersed into 15 ml of a mixture of THF/anhydrous diethyl ether (3:1), and the whole procedure was repeated five times. The resultant NHS-FA was dried under vacuum, overnight, to remove any residual ether and THF, and then stored at TS-FA nanoparticles were finally produced through a reaction of the NHS groups of the above obtained NHS-FA with the primary amine presented on the surface of TS-NH 2 ( Fig. 1 ).
TS-NH 2 nanoparticles (100 mg) were suspended in 10 ml of sodium carbonate/bicarbonate buffer solution (0.01 M, pH=9.0) using ultrasonic vibration at room temperature. Then, NHS-FA (289 mg) was dissolved into dry DMSO (10 ml) under magnetic stirring. The solution of NHS-FA in DMSO was added, dropwise, to the obtained nanoparticle suspension and the reaction was maintained at room temperature with constant stirring. After stirring in the dark for 2 h, the derived TS-FA nanoparticles were collected using a centrifuge at 7500 rpm for 15 min. The product was washed with DMSO (3×15 ml), followed by ethanol (1×15 ml), and dried overnight under vacuum.
Characterization of TS-NH 2 , NHS-FA, and TS-FA
Scanning electron micrographs of all nanoparticles produced were obtained using a FESEM (Zeiss Neon 40EsB FIB-SEM). Prior to FESEM examination, the sample suspension in Milli-Q water (20 g ml -1 ) was mounted on an aluminum stub. The aluminum stub was allowed to air-dry at ambient temperature overnight and then coated with platinum (2 nm) which was used as a conducting surface material. Operation of the microscope was carried out at an accelerating voltage of 5 kV. The mean diameter of the particles was analyzed using the SmartSEM software that was related to the scale bar for the recorded FESEM images. Sixty particles were randomly selected for size measurements.
The detailed morphology of the produced nanoparticles also were visualized using HRTEM (JEOL 3000F). The sample preparation for HRTEM examination was performed by placing one drop of the sample dispersion in ethanol solution (10 g ml (1 ml) and the mixture was added into the dry NMR tube.
The amine groups on the surface of TS-NH 2 particles were quantified using a back titration method [15] . In brief, TS-NH 2 nanoparticles (10 mg) and HCl aqueous solution (40 ml, 1.0 mM) were mixed with constant stirring for 2 h. Then, the mixture was separated using a centrifuge and the solid was discarded. The liquid was collected and titrated using an aqueous solution of NaOH (1.0 mM). Two drops of phenolphthalein in ethanol solution were added as a pH indicator.
Photoreactivity study
The photoreactivity of TS-NH 2 and TS-FA nanoparticles was determined based on phenol degradation efficiency. Pure TiO 2 (P25) and the silica-coated TiO 2 (TS) containing no folic acid also were assessed for comparison purposes. In brief, a preferred amount of catalyst was mixed with phenol solution (200 ml, 20 g ml for all nanoparticles. 
Cell culture and nanoparticle preparation
MTS assay
The MTS assay measured the absorbance of the formazan product which is formed by the
-2H-tetrazolium] (MTS) using dehydrogenase enzymes in living cells. The formed formazan product, recorded at 490 nm, is proportional to the number of living cells in the growth medium. A detailed description of the cytotoxicity assessment can be found in our previous paper [10] . For this work, the particle concentrations involved in MTS analysis were 12.5, 25, 50, 100, and 200 g ml -1 , respectively. A control experiment was performed using the cells treated with complete medium involving no particles, under identical conditions. Cells were incubated with the nanoparticles for 6 h and 24 h, respectively, prior to the MTS assessment. 
Hemolysis assay
Rabbit red blood cells (RBCs) were used for hemolysis studies of the samples using our reported procedure [10] . The sample concentrations were 12.5, 25, 50, 100, and 200 g ml -1 , respectively. For control purposes, the mixture of the RBC suspension (100 l) and PBS buffer (100 l) was applied as a negative control, while that of the RBC suspension (100 l) and 0.5% Triton X-100 (100 l) was used as a positive control. The percentage hemolysis was estimated using the equation below: 
Where A 576, sample , A 576, negative control , and A 576, positive control represent the absorbance of hemoglobin released from particle-treated RBCs, PBS buffer treated RBCs, and medium involving 0.5% Triton X-100 treated RBCs, respectively.
Photo-killing effect
To investigate the photo-killing effect of the derived nanoparticles under light, the cultured KB cells were trypsinized and suspended into culture medium at a concentration of 
Cell internalization
Prior to the cell internalization experiment, P25, TS, and TS-FA particles (20 mg each)
were separately suspended in a 0.5 ml acetone solution of fluorescein isothiocyanate (FITC) (1.0 mg ml -1 ). The suspensions were shaken overnight. Then, the particles were collected, using a centrifuge at 7500 rpm, and washed multiple times with Milli-Q water until the supernatant was clear. The resultant FTIC-labeled nanoparticles were then re-suspended into culture medium for further investigation.
To determine the intracellular uptake of the derived particles, KB cells, at a density of 
Statistical analysis
The results were expressed as meanstandard error. All the data were statically analyzed using Student's T-test. Statistical significances were considered at p<0.05.
Results and Discussion
Characterization of NHS-FA
FTIR was used to characterize NHS-FA in comparison with pure FA, as displayed in (Fig. 2b) , the signals at 2.50 and 3.30 ppm belong to the DMSO-d 6 and water, respectively. The signal at 11.35 ppm is attributed to the -OH proton in the carboxylic group of FA, while the signals at 8.65, 7.64, and 6.65 ppm are due to the aromatic protons of FA [21] . The signals presenting at 7.00 and 8.13 ppm belong to the -NH-protons in the p-amino benzoic acid moiety and the -CO-NH-in the glutamate moiety of FA, respectively [22] . The methylene protons in the pterin moiety and the glutamate moiety of FA appear at 4.48, 2.31, and 1.99-2.10 ppm, while the methylene protons of NHS can be observed at 2.8 ppm, indicating that FA has been successfully converted to NHS-ester of folic acid via DCC as a coupling agent [23] . The integration at 2.8 ppm revealed a higher than stoichiometric value (5.19 against 4), which is probably due to the presence of unreacted NHS. , presented in all samples' spectra, is assigned to the stretching vibration of O-H groups from the adsorbed water [10] , and the absorption peak at around 2150 cm -1
Characterization of TS-NH 2 and TS-FA nanoparticles
is from CO 2 in air.
The expanded spectra of TS-NH 2 and TS-FA in the region 1300-1700 cm , which is comparable to the data obtained from TGA.
Photocatalytic reactivity
The photoreactivity of the obtained nanoparticles was evaluated on the basis of phenol degradation in the presence of UV light. Fig. 5b shows the percentage degradation of phenol using P25, TS, TS-NH 2 , and TS-FA at the given time intervals. Upon exposure to UV light for 150 min, complete removal of phenol with an initial concentration of 20 g ml The reduction of photodegradation rate after the encapsulation of TiO 2 in silica shell is consistent with our previous observation, which is mostly due to the shielding effect of the silica matrix and the increase in nanoparticle sizes [10] . Folation of the TS nanoparticles has resulted in a slight reduction of the degradation rate constant from the 0.0084 min -1 of TS to 0.0066 min -1 of TS-FA, which is probably due to the increased size of TS-FA. A very low value of rate constant was shown by the intermediate TS-NH 2 nanoparticles, which is probably due to the competing photo-oxidation of primary amine groups on the surface of the TS-NH 2 . A study has shown that, under UV illumination, the ROS generated from photoexcited TiO 2 nanoparticles can oxidize primary amine groups to yield NO 3 -ions, and the cleavage rate of the C-N bond from primary amine is faster than that of the C-C bond in the hydrocarbon molecules [29] . A toxicity study of P25, TS, and TS-FA nanoparticles on KB cells also was conducted.
The study was carried out by exposing the cells to the nanoparticles at the prescribed concentrations, shown in Fig. 6b . Similar to the results for the L929 cells, after 6 h incubation, no apparent differences in cell viability ( * p>0.05) were observed between control cells and cells treated with P25, TS, and TS-FA over the investigated concentrations. When the incubation time was increased to 24 h, the viability of TS-treated cells was decreased to 73.3% and 79.7%, respectively, in the presence of 100 and 200 g ml -1 of nanoparticles. The toxic effect of TS nanoparticles on KB cells in the dark is possibly due to the higher toxicity of silica towards cancerous cells [30] . This is indeed true when comparing the KB cell viability with the L929 cell viability after the cells were treated with TS nanoparticles. In the presence of 100 and 200 g ml -1 of TS nanoparticles, the cell viability was 98.5% and 96.5% respectively for L929, and 73.3% and 79.7% for KB cells (Fig. 6) . We speculate that the viability of TS-treated cells vary from one cell line to another. Similar results have been reported by other researchers [31] .
For TS-FA-treated KB cells, a concentration-dependent increase in viability was observed， which further demonstrates the nutritional effect of the folate component in the nanoparticles.
It is interesting to note that TS-FA also displayed a degree of toxicity towards the cancerous KB cells. This is particularly obvious at the lower concentration range. For instance, when the concentration of TS-FA was 12.5, 25, and 50 µg ml -1 , the cell viability for L929 was 200%, 196%, and 196%, respectively, whilst that for KB cells was 173%, 182%, and 194%. The overall enhancement in cell proliferation by TS-FA nanoparticles was demonstrated for both L929 and KB cells. Repeated experiments show similar effect. This could be a result of high FA-composition in the TS-FA nanoparticles. As we know that folic acid is often used in the growth medium to promote cell growth. In a standard growth medium, the concentration of folic acid is approximately 1.01 g ml -1 [32] . In this study, the produced TS-FA contained 4. Fig. 7a shows the in vitro hemolysis results of P25, TS, and TS-FA at a similar particle concentration range. The detected hemoglobin release is well below 5% over the investigated concentration range, indicating a good compatibility of these nanoparticles with the blood cells. A relatively high hemolysis activity was seen when the RBC was treated with the nanoparticles at a particle concentration of 50 g ml -1 . The activity was reduced at both a higher and a lower concentration. We speculate that, although increased amounts of nanoparticles lead to more active hemolysis, it also increases the opportunity for the nanoparticles to aggregate, thereby decreasing the surface area that can interact with the RBCs. There is no fluorescence seen in both the control cells and the TS-treated cells. The phase contrast images (Fig.8b) further demonstrated that the dosage of P25 internalized by KB cells is generally lower than that of TS-FA. This is most likely due to the presence of the folate component on the surface of TS-FA nanoparticles, which are able to be specifically bound with the folate receptors on the folate-receptor positive KB cells. It is apparent that the higher photo-killing effect of the TS-FA nanoparticles also is associated with the stronger cell internalization. It should be noted that 194% of viable KB cells were observed when they were treated with the same amounts of TS-FA in the dark for 24 h. The detected photo-killing effect of TS-FA in the previous section could have been reduced by such enhanced growth. A higher photo-killing power can be achieved by fine tuning the nanoparticles by controlling the FA density on the surface of the nanoparticles. To the best of our knowledge, this is the first study on folic acid-conjugated titanium dioxide-silica (TS-FA) nano-photosensitizer for effective PDT. Early studies on pure TiO 2 nanoparticles by Cai et al. have shown a complete photo-killing of HeLa cells after 10 min exposure to a Hg-lamp (500 W) [13] . There was no indication of the effect to the cells by the high power radiation alone. Antibody has been used for cell specific targeting using TiO 2 nanoparticles for effective PDT. One study [34] has shown that, with 30 min irradiation of a UV-light at 365 nm, the surviving fraction of LoVo cells was reduced from 84% to 67% due to the presence of 3.12 µg/ml antibody-modified TiO 2 nanoparticles. No data was reported about the effect of higher concentration nanoparticles. A similar study was reported by a different group, in which 80% cell death (by cell counting) was induced by the polyacrylic acid-coated TiO 2 that is modified with anti-epidermal growth factor receptor antibody [35] . No control data was provided in this study. Nitrogen-doped TiO 2 nanoparticles was also investigated for visible light irradiation induced PDT, however no targeting ligand was considered [36] .
Hemocompatibility study
Photo-killing effect
Conclusions
In summary, a novel folic acid-conjugated titanium dioxide-silica core-shell nanoparticulate system, TS-FA, was fabricated using the commercially available semiconductor photocatalyst, P25, and confirmed by various chemical and physical characterization methods. Investigations on the cytotoxicity and hemocompatibility showed that the produced TS-FA nanoparticles are nontoxic to both L929 and KB cells in the dark, and are well tolerated by human red blood cells. A strong increase in viability of both L929 and KB cells was demonstrated after cells were incubated with TS-FA in the range between 12.5 and 200 µg ml -1 , showing that the presence of the folate element acts as a nutrient for the cells. Upon exposure to UV light for 10 min, both P25 and TS-FA were toxic to KB cells due to their high photocatalytic activities. The cell internalization experiments proved that folic acid-conjugated nanoparticles were bound to the folate receptor-positive KB cells, indicating a high ability to target cancerous cells. The dual targeting capabilities, through both the folic acid conjugation and high photoexcitation efficiency of the TS-FA system, promises great potential in the treatment of cancer, and possibly other diseases. It is worth noting the strong concentration dependence of the photo-killing effects that was observed in the cells exposed to TS-FA, and the improved compatibility of TS-FA with both L929 and KB cells due to the 'nutritional effect' of the folate components in the nanoparticles. Although a high photo-killing effect of 38-43% on the KB cells has been achieved in this study, the nanoparticulate system can be further tuned to maximize its photo-killing power. A systematic study is under way to optimize the folate content in the nanoparticles so as to achieve an optimal photo-killing ability to a greater variety of cancerous cells. The development and 
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